Ensign Peak Advisors, Inc Karuna Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

$54.2 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $825,820 - $1.63 Million	5,129 Added 3.63%	146,467 $46.4 Million
Q3 2023 Nov 13, 2023	SELL	$164.66 - $218.08 $5.88 Million - $7.79 Million	-35,726 Reduced 20.18%	141,338 $23.9 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $6.3 Million - $8.59 Million	35,749 Added 25.3%	177,064 $38.4 Million
Q4 2022 Feb 13, 2023	SELL	$191.53 - $236.82 $6.61 Million - $8.17 Million	-34,498 Reduced 19.62%	141,315 $27.8 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $4.97 Million - $11.1 Million	-40,144 Reduced 18.59%	175,813 $39.5 Million

Q2 2022 Aug 12, 2022	SELL	$93.97 - $143.33 $4.04 Million - $6.16 Million	-43,004 Reduced 16.61%	215,957 $27.3 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $281,865 - $377,254	2,850 Added 1.11%	258,961 $32.8 Million
Q4 2021 Feb 11, 2022	SELL	$110.64 - $159.4 $1.48 Million - $2.14 Million	-13,408 Reduced 4.97%	256,111 $33.6 Million
Q3 2021 Nov 12, 2021	SELL	$101.2 - $125.87 $1.7 Million - $2.11 Million	-16,787 Reduced 5.86%	269,519 $33 Million
Q2 2021 Aug 13, 2021	BUY	$107.45 - $135.95 $355,981 - $450,402	3,313 Added 1.17%	286,306 $32.6 Million
Q1 2021 May 12, 2021	BUY	$95.46 - $133.08 $8.03 Million - $11.2 Million	84,105 Added 42.29%	282,993 $34 Million
Q4 2020 Feb 12, 2021	BUY	$75.23 - $109.23 $2.03 Million - $2.95 Million	26,996 Added 15.71%	198,888 $20.2 Million
Q3 2020 Nov 12, 2020	BUY	$71.31 - $109.74 $5.69 Million - $8.75 Million	79,752 Added 86.56%	171,892 $13.3 Million
Q2 2020 Aug 12, 2020	BUY	$62.14 - $117.21 $183,126 - $345,417	2,947 Added 3.3%	92,140 $10.3 Million
Q1 2020 May 11, 2020	SELL	$60.41 - $115.92 $862,231 - $1.65 Million	-14,273 Reduced 13.79%	89,193 $6.42 Million
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $1.18 Million - $12.8 Million	103,466 New	103,466 $7.8 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

333K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account